Results 21 to 30 of about 6,145 (277)

Midodrine initiation criteria, dose titration, and adverse effects when administered to treat shock: A systematic review and semi-quantitative analysis. [PDF]

J Crit Care Med (Targu Mures)
Puissant MM, Armstrong KJ, Riker RR, Haydar S, Strout TD, Smith KE, Seder DB, Gagnon DJ.   +7 more
europepmc   +2 more sources

Haematological toxicity of midodrine in haemodialysis patients [PDF]

Nephrology Dialysis Transplantation, 2000
Hassane Izzedine, Raymond Azar, K Zahiri, Jacques Rottembourg, Gilbert Deray   +4 more
openalex   +4 more sources

Midodrine and Weekly Albumin Therapy in Patients With Cirrhosis and Diuretic Intractable or Recurrent Ascites: A Case-Control Study. [PDF]

Cureus
Borah GJ, Pande G, Malakar S, Kumar SR, Yadav RR, Mohindra S.   +5 more
europepmc   +2 more sources

Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Systematic Review and Meta-Analysis. [PDF]

Crit Care Med
OBJECTIVES: To summarize the efficacy of midodrine as an adjunctive therapy in critically ill patients. Safety of midodrine was assessed as a secondary outcome. DATA SOURCES: We performed a systematic review and meta-analysis using a peer-reviewed search
Kilcommons SJ, Hammal F, Kamaleldin M, Opgenorth DL, Fiest KM, Karvellas CJ, Kutsogiannis DJ, Lau VI, MacIntyre EJ, Rochwerg B, Senaratne JM, Slemko JM, Sligl WI, Wang XXM, Bagshaw SM, Rewa OG.   +15 more
europepmc   +2 more sources

Midodrine Efficacy in Orthostatic Hypotension [PDF]

Journal of General Internal Medicine, 2014
To the Editors—We recently came across the review article by Parsaik et al. “Midodrine for Orthostatic Hypotension: A Systematic Review and Meta-Analysis of Clinical Trials” (J Gen Intern Med 28(11): 1496–503), and feel obligated to comment on several deficiencies of this work.
Wolfgang Singer, M. J. Joyner, Paola Sandroni, Eduardo E. Benarroch, Robert D. Fealey, Jayawant N. Mandrekar, Phillip A. Low   +6 more
  +10 more sources

Calcitonin gene-related peptide predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope

Frontiers in Neuroscience, 2022
The vasoconstriction agent midodrine hydrochloride is a vital treatment for pediatric patients diagnosed with vasovagal syncope (VVS), although the efficacy is variable.
Lintian Li, Huacai Zhao, Xiuxiu Ma, Fuyong Jiao, Jing Lin   +4 more
doaj   +1 more source

Stimulation of Alpha-1-Adrenergic Receptor Ameliorates Obesity-Induced Cataracts by Activating Glycolysis and Inhibiting Cataract-Inducing Factors [PDF]

Endocrinology and Metabolism, 2022
Background Obesity, the prevalence of which is increasing due to the lack of exercise and increased consumption of Westernized diets, induces various complications, including ophthalmic diseases. For example, obesity is involved in the onset of cataracts.
Yong-Jik Lee, Yoo-Na Jang, Hyun-Min Kim, Yoon-Mi Han, Hong Seog Seo, Youngsub Eom, Jong-suk Song, Ji Hoon Jeong, Tae Woo Jung   +8 more
doaj   +1 more source

Idiopathic orthostatic hypotension, midodrine, and anaesthesia [PDF]

Canadian Journal of Anaesthesia, 1991
A patient with idiopathic orthostatic hypotension receiving chronic oral midodrine therapy required anaesthesia for coronary artery bypass grafting. A perioperative infusion of phenylephrine was substituted for midodrine, an alpha-2 agonist, enabling hypotension resulting from low systemic vascular resistance to be controlled easily.
P. J. Osborne, L. W. Lee
openalex   +5 more sources

Exploring the Efficacy of Midodrine for Tapering Off Vasopressors. [PDF]

Cureus
Sepsis and septic shock represent critical conditions, often necessitating vasopressor support in the intensive care unit (ICU). Midodrine, an oral vasopressor, has gathered attention as a potential adjunct to vasopressor therapy, aiming to facilitate ...
Athar ZM, Arshad M, Shrivastava S.
europepmc   +2 more sources

Enteral Midodrine for Intravenous Vasopressor Weaning in Acute Traumatic Spinal Cord Injury Patients. [PDF]

Hosp Pharm
Background: Enteral vasopressor therapies have been used to facilitate the weaning of intravenous (IV) vasopressors in critically ill patients. Studies have shown mixed results in the medically critically ill population; however, this practice is still ...
Chau T, Colosimo C, Delic J, Igneri LA, Solomon D, Wang JL.   +5 more
europepmc   +2 more sources